跳至主要内容
临床试验/NCT03018301
NCT03018301Unknown2 期

Effect of Single Intravenous Ketamine Dose on Postoperative Pain Following Cesarean Section Under Spinal Anesthesia: A Randomized Control Clinical Trial.

Assiut University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
80
试验地点
1
主要终点
• Number of Subjects Requiring Supplemental Analgesia

研究概览

简要总结

The purpose of this study is to investigate the analgesic effect of low-dose intravenous ketamine in pregnant mothers undergoing cesarean section under Bupivacaine spinal anesthesia.

详细描述

  • No premedication will be given, and patients will be monitored by electrocardiogram, non-invasive arterial blood pressure, and pulse oximetry when they entered the operating room.
  • 18 gauge IV cannula will be inserted and all patients will be preloaded with 10 ml/kg of lactate ringer over 20 min period.
  • All participants will have spinal anesthesia using bupivacaine. The dose of the drug, as well as the method of injection will be identical for all individuals; 10 mg (2 cc 0.5%), in the L4-L5 space using needle 25 G, midline, with the patient in a sitting position.
  • After administering bupivacaine, and prior to surgery the height of the sensory block will be assessed bilaterally (complete loss of sensation to ice) in a ascending fashion starting from T12 dermatome.
  • Once adequate anesthesia to at least T6 dermatome will be achieved, the operation will be allowed to begin. When systolic blood pressure decrease to < 90 mmHg, or 30% of the pre-anesthetic blood pressure, it will be corrected by administering 5 mg ephedrine.
  • Patients will be asked to report any intraoperative pain using visual pain score(VPS)of 0(no pain) 10(worst pain).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Eligible women ASA class 1 and 2, are at term (≥37 week gestation), Scheduled for elective cesarean section whose anesthetic plan is for spinal anesthesia with Bupivacaine and intravenous pethidine and paracetamol for post operative analgesia.

排除标准

  • • Body mass index ≥40 kg/m2,
  • Known allergy to any of the study medications,
  • Contraindication to the spinal anesthesia,
  • History of substance abuse,
  • History of hallucinations,
  • Chronic opioid therapy,
  • Chronic pain.

研究组 & 干预措施

Ketamine group

Active Comparator

will receive 0.25 mg/kg intravenous ketamine diluted with normal saline to 20 ml delivered over 10 minutes.

干预措施: Ketamine (Drug)

Control group

Placebo Comparator

will receive intravenous 20 ml of normal saline, delivered over 10 minutes.

干预措施: Normal saline (Other)

结局指标

主要结局

• Number of Subjects Requiring Supplemental Analgesia

时间窗: 24 hours postoperative

次要结局

  • Cumulative morphine/paracetamol(24 hours postoperative)
  • Number of subjects reporting nausea, vomiting(24 hours postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrady S Ibrahim, MD

Assistant professor of anesthesia and ICU

Assiut University

研究点 (1)

Loading locations...

相似试验

Intravenous Ketamine and Postoperative Pain... | 临床试验